When most people think about hormone replacement therapy, they think about the decision to take it or not. What doesn't get nearly enough attention is the decision that comes right after: how you take it.

Because it turns out that the delivery method — specifically whether estrogen goes through your digestive system or directly through your skin — changes what it does in your body in ways that are clinically significant. This isn't a minor detail. For some women, it's the difference between a therapy that works beautifully and one that causes problems.

Let's break it down.

The First Pass: Why Your Liver Is Part of This Conversation

When you swallow an oral estrogen pill, it gets absorbed through your gut and travels directly to your liver before it ever reaches your bloodstream. This is called the first-pass effect — and it has real consequences.

Your liver, encountering this flood of estrogen, responds by ramping up the production of several proteins. Some of these are helpful. Many are not. The first-pass effect from oral estrogen is responsible for most of the meaningful differences between oral and transdermal therapy.

Transdermal estrogen — delivered through a patch, gel, spray, or cream applied to the skin — bypasses the liver entirely. It absorbs directly into the bloodstream and delivers estradiol in a form that closely mimics what your ovaries produced naturally. The liver never sees a large bolus of it all at once.

This distinction matters more than most women — and even many providers — realize.

Clot Risk: This One Is Important

One of the most significant differences between oral and transdermal estrogen is their effect on blood clot risk.

Oral estrogen increases the liver's production of clotting factors. Multiple studies — including large observational studies and the ESTHER study specifically designed to examine this — have found that oral estrogen is associated with a meaningfully increased risk of venous thromboembolism (blood clots, including deep vein thrombosis and pulmonary embolism). The risk is still relatively small in absolute terms, but it is real and consistent across the research.

Transdermal estrogen, because it bypasses the liver, does not appear to carry this same increased clot risk. Studies consistently show that transdermal estradiol at standard doses has a clot risk profile essentially equivalent to taking nothing at all.

This is especially relevant for women who have a personal or family history of clotting disorders, are overweight, smoke, or have other cardiovascular risk factors. For these women, transdermal is not just preferable — it may be significantly safer.

Blood Pressure and Triglycerides

Oral estrogen stimulates the liver to produce more angiotensinogen, a protein involved in blood pressure regulation, which can raise blood pressure in some women. It also raises triglycerides, which is a cardiovascular risk factor in its own right.

Transdermal estrogen has a neutral to slightly beneficial effect on both. Some research actually shows modest improvements in triglyceride levels with transdermal delivery.

For women who already have elevated blood pressure or triglycerides — which becomes increasingly common in perimenopause and menopause — this is a meaningful consideration.

Estradiol vs. Estrone: The Quality of the Estrogen Matters Too

Here's something that rarely gets discussed: oral estrogen doesn't just go through the liver — it gets partially converted there. Much of what you absorb from an oral estrogen pill ends up as estrone (E1) rather than estradiol (E2). Estradiol is the primary, most potent estrogen your body made during your reproductive years. Estrone is a weaker, less active form.

Transdermal estradiol delivers actual estradiol into the bloodstream — the same molecule your ovaries produced. This means your tissues, including your brain, bones, and cardiovascular system, are receiving the estrogen they were designed to use.

Whether this difference translates into meaningful clinical outcomes is still being studied, but it's one reason many hormone specialists prefer transdermal delivery as the more physiologic option.

So Is Oral Estrogen Ever the Right Choice?

Yes. There are situations where oral estrogen makes sense:

Some women simply prefer a pill — the familiarity, the simplicity, not having to think about application sites or transfer to a partner. For healthy women with no clotting risk factors and no blood pressure or triglyceride concerns, oral estrogen is a legitimate option.

Oral estrogen also raises SHBG (sex hormone binding globulin) more than transdermal, which can occasionally be useful or harmful in certain clinical contexts.

And practically speaking, oral estrogen is often less expensive and more consistently covered by insurance than some transdermal formulations.

What Transdermal Options Look Like

Transdermal estradiol comes in several forms, each with slightly different characteristics:

Patches — worn on the skin and changed once or twice a week depending on the formulation. Consistent delivery, easy to forget about once applied. Some women develop skin reactions at the adhesion site.

Gels — applied daily to the arm or thigh, dries quickly. Dosing is flexible and easy to adjust. The most common gel prescribed in the US is Divigel; EstroGel is another option. Requires care about transfer to others until dry.

Creams — similar to gels, often compounded. Biest cream, which combines estradiol and estriol, is a compounded option some practices prefer for its flexibility in dosing.

Sprays — a metered-dose spray applied to the forearm, less commonly used but available.

Vaginal Rings — a great option for a non oral delivery method, but can be expensive.

Vaginal estradiol — for genitourinary symptoms specifically (dryness, discomfort, recurrent UTIs), low-dose vaginal estradiol like Estrace cream, Imvexxy, or the Estring ring acts locally with minimal systemic absorption. This is often used in addition to systemic therapy, not instead of it.

The Bottom Line

The form of estrogen you take is not just a matter of preference or convenience — it has real implications for safety and effectiveness. For most women, particularly those with any cardiovascular risk factors or clotting concerns, transdermal estradiol is the preferred option based on the current evidence. It more closely mimics your body's natural estrogen, avoids the liver's first-pass effects, and carries a more favorable safety profile.

That said, every woman's situation is different. The right choice depends on your health history, your risk factors, your lifestyle, and what you're trying to achieve. This is exactly the kind of nuanced conversation we have with every patient at The Lee Clinic — because you deserve a provider who knows the difference and can help you make the most informed decision possible.

The Lee Clinic sees patients in person in Winchester and Reston, VA. Telehealth appointments are available for patients in FL, DC, WV, and MD. Call us at 540-542-1700 to schedule.